• Episode 47. ASCO/EHA 2024 Lymphoma Updates with Dr. Gloria Iacoboni

  • Jul 6 2024
  • Duración: 48 m
  • Podcast

Episode 47. ASCO/EHA 2024 Lymphoma Updates with Dr. Gloria Iacoboni

Escúchala gratis

Ver detalles del espectáculo

  • Resumen

  • In this episode, we reviewed the hottest updates in lymphoma from ASCO and EHA 2024, held in Chicago and Madrid respectively, with Dr. Gloria Iacoboni, a haematologist from University Hospital Vall d'Hebron, in Barcelona, Spain. Here are the key abstracts we discussed:

    1. STARGLO: Glofit-GEMOX vs R-GEMOX in relapsed/refractory DLBCL

    https://library.ehaweb.org/eha/2024/eha2024-congress/4136516

    2. Epco-Pola-R-CHP for 1st line DLBCL (EPCORE NHL-5 study):

    https://library.ehaweb.org/eha/2024/eha2024-congress/422343

    3. 3-year follow-up of TRANSFORM (Liso-Cel vs CITàASCT in R/R DLBCL): https://meetings.asco.org/abstracts-presentations/232740

    4. ECHO RCT: Acalabrutinib-BR vs Placebo-BR in previously untreated elderly MCL: https://library.ehaweb.org/eha/2024/eha2024-congress/4136515

    5. HD21: escBEACOPP vs BrECADD in 1st line classical HL: https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(24)01315-1/fulltext

    6. Combination pirtobrutinib, venetoclax, and obinutuzumab in 1st line CLL: https://library.ehaweb.org/eha/2024/eha2024-congress/422268

    7. Single-agent epcoritamab in Richter’s transformation: EPCORE CLL-1: https://library.ehaweb.org/eha/2024/eha2024-congress/422267
    Más Menos
Enfermedades Físicas Hygiene & Healthy Living
Más Menos

Lo que los oyentes dicen sobre Episode 47. ASCO/EHA 2024 Lymphoma Updates with Dr. Gloria Iacoboni

Calificaciones medias de los clientes

Reseñas - Selecciona las pestañas a continuación para cambiar el origen de las reseñas.

Reseñas de Audible.com

Opiniones de Amazon
No hay comentarios disponibles